HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hibernation-like state induced by an opioid peptide protects against experimental stroke.

AbstractBACKGROUND:
Delta opioid peptide [D-ala2,D-leU5]enkephalin (DADLE) induces hibernation in summer ground squirrels, and enhances preservation and survival of isolated or transplanted lungs and hearts. In the present study, we investigated the protective effect of DADLE in the central nervous system.
RESULTS:
Adult Sprague-Dawley rats were pretreated with DADLE (4 mg/kg every 2 h x 4 injections, i.p.) or saline prior to unilateral occlusion of the middle cerebral artery (MCA). Daily behavioral tests revealed that ischemic animals treated with DADLE did not show any significant behavioral dysfunctions compared with saline-treated ischemic animals. Opioid antagonists only transiently inhibited the protective effect of DADLE, indicating the participation of non-opioid mechanisms in DADLE neuroprotection. Histological examination using triphenyltetrazolium chloride (TTC) revealed that brains from ischemic animals treated with DADLE, either alone or with adjuvant opioid blockers, exhibited almost completely intact striata. In contrast, brains from ischemic animals that received saline showed significant infarction in the lateral striatum. Analyses of apoptotic cell death revealed a significant increase in the p-53 mRNA expression in the striatum of ischemic animals that received saline, while those that received DADLE exhibited near normal striatal p-53 expression. This protective effect was accompanied by significant increments in protein levels of glial cell line-derived neurotrophic factor in the striatum of DADLE-treated ischemic animals.
CONCLUSION:
These results indicate that DADLE protected against necrotic and apoptotic cell death processes associated with ischemia-reperfusion injury. The present study demonstrates that delta opioids are crucially involved in stroke, suggesting that the opioid system is important in the study of brain injury and protection.
AuthorsCesar V Borlongan, Teruo Hayashi, Peter R Oeltgen, Tsung-Ping Su, Yun Wang
JournalBMC biology (BMC Biol) Vol. 7 Pg. 31 (Jun 17 2009) ISSN: 1741-7007 [Electronic] England
PMID19534760 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Glial Cell Line-Derived Neurotrophic Factor
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • Enkephalin, Leucine-2-Alanine
Topics
  • Animals
  • Apoptosis
  • Brain (drug effects)
  • Brain Infarction (metabolism, pathology, prevention & control)
  • Brain Ischemia (drug therapy)
  • Disease Models, Animal
  • Enkephalin, Leucine-2-Alanine (therapeutic use)
  • Glial Cell Line-Derived Neurotrophic Factor (metabolism)
  • Hibernation (drug effects)
  • Motor Activity (drug effects)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Suppressor Protein p53 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: